These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22997720)

  • 21. Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions.
    Pretnar-Oblak J; Sabovic M; Sebestjen M; Pogacnik T; Zaletel M
    Stroke; 2006 Oct; 37(10):2540-5. PubMed ID: 16931784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia.
    Goldberg AC; Bays HE; Ballantyne CM; Kelly MT; Buttler SM; Setze CM; Sleep DJ; Stolzenbach JC
    Am J Cardiol; 2009 Feb; 103(4):515-22. PubMed ID: 19195513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
    J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An association study between catalase -262C>T gene polymorphism, sodium-lithium countertransport activity, insulin resistance, blood lipid parameters and their response to atorvastatin, in Greek dyslipidaemic patients and normolipidaemic controls.
    Kosmidou M; Hatzitolios AI; Molyva D; Raikos N; Savopoulos C; Daferera N; Kokkas V; Goulas A
    Free Radic Res; 2009 Apr; 43(4):385-9. PubMed ID: 19274593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia.
    Bashir S; Sherwani MU; Shabbir I; Batool A
    J Ayub Med Coll Abbottabad; 2011; 23(3):97-100. PubMed ID: 23272446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atorvastatin and fenofibric acid differentially affect the release of adipokines in the visceral and subcutaneous cultures of adipocytes that were obtained from patients with and without mixed dyslipidemia.
    Łabuzek K; Bułdak Ł; Duława-Bułdak A; Bielecka A; Krysiak R; Madej A; Okopień B
    Pharmacol Rep; 2011; 63(5):1124-36. PubMed ID: 22180354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
    Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The aggregation capacity of neutrophils in patients with arterial hypertension and dyslipidemia treated with fluvastatin].
    Medvedev IN; Skoryatina IA
    Klin Med (Mosk); 2015; 93(1):66-70. PubMed ID: 26031153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A low-density lipoprotein-dependent effect of atorvastatin upon the systolic blood pressure reduction: meta-regression analyses of randomized trials.
    Takagi H; Umemoto T;
    Int J Cardiol; 2013 Dec; 170(1):e14-6. PubMed ID: 24169537
    [No Abstract]   [Full Text] [Related]  

  • 30. HMG-CoA reductase inhibitors and renal function.
    Campese VM; Park J
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1100-3. PubMed ID: 17942762
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor.
    Stern RH; Yang BB; Hounslow NJ; MacMahon M; Abel RB; Olson SC
    J Clin Pharmacol; 2000 Jun; 40(6):616-23. PubMed ID: 10868312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mean platelet volume measurement in patients with hypercholesterolemia: a methodological issue.
    Varol E; Ozaydin M
    Angiology; 2013 Nov; 64(8):626. PubMed ID: 23709475
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin.
    Trifiletti A; Lasco A; Scamardi R; Pizzoleo MA; Gaudio A; La Rocca R; Morini E; Frisina N
    Pathophysiol Haemost Thromb; 2003; 33(2):84-7. PubMed ID: 14624049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-pill combination of amlodipine besylate and atorvastatin calcium.
    Blank R
    Drugs Today (Barc); 2006 Mar; 42(3):157-75. PubMed ID: 16628258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia.
    Poolsup N; Suksomboon N; Wongyaowarat K; Rungkanchananon B; Niyomrat P; Kongsuwan S
    J Clin Pharm Ther; 2012 Apr; 37(2):166-72. PubMed ID: 21585411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
    Samy W; Hassanian MA
    Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
    Wamhoff BR; Dixon JL; Sturek M
    J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins and fibrinogen.
    Darko DA; O'Shea D
    Lancet; 1998 May; 351(9113):1431; author reply 1431-2. PubMed ID: 9593433
    [No Abstract]   [Full Text] [Related]  

  • 39. Statins and fibrinogen.
    Black DM
    Lancet; 1998 May; 351(9113):1430; author reply 1431-2. PubMed ID: 9593431
    [No Abstract]   [Full Text] [Related]  

  • 40. [Estimation of antioxidative effect of atorvastatin and fluvastatin used in primary prevention of coronary heart disease--effect on lipid peroxidation].
    Kowalski J; Pawlicki L; Grycewicz J; Błaszczyk J; Irzmański R; Cegliński T; Kowalczyk E; Liban-Gałka B
    Wiad Lek; 2005; 58(7-8):386-90. PubMed ID: 16425789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.